| Baseline surveillance in Li-Fraumeni syndrome using whole-body magnetic resonance imaging: a meta-analysis ML Ballinger, A Best, PL Mai, PP Khincha, JT Loud, JA Peters, MI Achatz, ... JAMA oncology 3 (12), 1634-1639, 2017 | 171 | 2017 |
| The impact of sentinel node-mapping in staging high-risk endometrial cancer G Baiocchi, H Mantoan, LY Kumagai, BT Gonçalves, L Badiglian-Filho, ... Annals of surgical oncology 24 (13), 3981-3987, 2017 | 47 | 2017 |
| Is parametrectomy always necessary in early-stage cervical cancer? G Baiocchi, L de Brot, CC Faloppa, H Mantoan, MR Duque, ... Gynecologic Oncology 146 (1), 16-19, 2017 | 43 | 2017 |
| Hyperthermic intraperitoneal chemotherapy after secondary cytoreduction in epithelial ovarian cancer: a single-center comparative analysis G Baiocchi, FO Ferreira, H Mantoan, AABA Da Costa, CC Faloppa, ... Annals of surgical oncology 23 (4), 1294-1301, 2016 | 43 | 2016 |
| A Replication stress biomarker is associated with response to gemcitabine versus combined gemcitabine and ATR inhibitor therapy in ovarian cancer PA Konstantinopoulos, AA da Costa, D Gulhan, EK Lee, SC Cheng, ... Nature communications 12 (1), 1-8, 2021 | 39 | 2021 |
| Genomic profiling of platinum-resistant ovarian cancer: The road into druggable targets AABA da Costa, G Baiocchi Seminars in cancer biology 77, 29-41, 2021 | 30 | 2021 |
| Angiogenesis-related protein expression in bevacizumab-treated metastatic colorectal cancer: NOTCH1 detrimental to overall survival TF Paiva, VHF de Jesus, RA Marques, AABA da Costa, MP de Macedo, ... BMC cancer 15 (1), 1-12, 2015 | 30 | 2015 |
| Risk factors for pelvic and distant recurrence in locally advanced cervical cancer ACM Queiroz, V Fabri, H Mantoan, SM Sanches, APG Guimarães, ... European Journal of Obstetrics & Gynecology and Reproductive Biology 235, 6-12, 2019 | 26 | 2019 |
| Impact of sentinel node mapping in decreasing the risk of lymphocele in endometrial cancer TP Diniz, E Drizlionoks, CC Faloppa, JN Menezes, H Mantoan, ... Annals of Surgical Oncology 28 (6), 3293-3299, 2021 | 18 | 2021 |
| Prostaglandin D2 expression is prognostic in high‑grade serous ovarian cancer MR Alves, NS Do Amaral, FA Marchi, FIDB Silva, AABA Da Costa, ... Oncology reports 41 (4), 2254-2264, 2019 | 16 | 2019 |
| The value of secondary cytoreductive surgery in recurrent ovarian cancer and application of a prognostic score AABA Da Costa, CV Valadares, H Mantoan, A Saito, MM Salvadori, ... International Journal of Gynecologic Cancer 26 (3), 2016 | 15 | 2016 |
| Adnexal involvement in endometrial cancer: prognostic factors and implications for ovarian preservation G Baiocchi, AG Clemente, H Mantoan, WL da Costa, G Bovolim, ... Annals of Surgical Oncology 27 (8), 2822-2826, 2020 | 11 | 2020 |
| Para‐aortic lymphadenectomy can be omitted in most endometrial cancer patients at risk of lymph node metastasis G Baiocchi, CC Faloppa, H Mantoan, WR Camarço, L Badiglian‐Filho, ... Journal of surgical oncology 116 (2), 220-226, 2017 | 10 | 2017 |
| Case Report of Small Cell Carcinoma of the Ovary, Hypercalcemic Type (Ovarian Rhabdoid Tumor) with SMARCB1 Mutation: A Literature Review of a Rare and … MFE Simões, AABA da Costa, TN Silva, L Fernandes, G Bovolim, ... Current Oncology 29 (2), 411-422, 2022 | 8 | 2022 |
| Size of sentinel node metastasis predicts non-sentinel node involvement in endometrial cancer G Baiocchi, H Mantoan, BT Gonçalves, CC Faloppa, LY Kumagai, ... Annals of Surgical Oncology 27 (5), 1589-1594, 2020 | 8 | 2020 |
| Prognostic factors in locally advanced cervical cancer with pelvic lymph node metastasis PJJ Pinto, MJ Chen, ES Neto, CC Faloppa, L De Brot, APG Guimaraes, ... International Journal of Gynecologic Cancer 32 (3), 2022 | 7 | 2022 |
| Impact of BRCA1/2 Mutations on the Efficacy of Secondary Cytoreductive Surgery FL Estati, R Pirolli, VTL de Alencar, ARG Ribeiro, MN Formiga, ... Annals of Surgical Oncology 28 (7), 3637-3645, 2021 | 7 | 2021 |
| Retrospective analysis of the role of cyclin E1 overexpression as a predictive marker for the efficacy of bevacizumab in platinum-sensitive recurrent ovarian cancer ARG Ribeiro, MM Salvadori, L de Brot, G Bovolin, H Mantoan, F Ilelis, ... ecancermedicalscience 15, 2021 | 7 | 2021 |
| PARP Inhibitors in Ovarian Cancer. A da Costa The New England journal of medicine 382 (16), 1572-1573, 2020 | 7 | 2020 |
| Prognostic value of GRIM-19, NF-κB and IKK2 in patients with high-grade serous ovarian cancer F Ilelis, NS do Amaral, MR Alves, AABA da Costa, VF Calsavara, ... Pathology-Research and Practice 214 (2), 187-194, 2018 | 6 | 2018 |
